StockData
Bio Key International Inc logo

Bio Key International Inc (BKYI) stock

BKYINasdaqServices-Prepackaged SoftwareFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/3072% below fair value
$1.99+0.05 (+2.58%)

Close on Nov 18, 2026Market cap $2.86MP/E –Yield –

Bio Key International operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Bio Key International's operating income for the twelve months ending Jun 30, 2026 was -$5.79M. For fiscal 2025 it was -$6.83M. The highest annual figure on record is $27.89K in fiscal 2012.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$6.83M–
FY2024Dec 31, 2024-$4.01M–
FY2023Dec 31, 2023-$8.83M–
FY2022Dec 31, 2022-$9.92M–
FY2021Dec 31, 2021-$4.94M–
FY2020Dec 31, 2020-$5.20M–
FY2019Dec 31, 2019-$1.07M-1336325.0%
FY2018Dec 31, 2018$80–
FY2017Dec 31, 2017-$4.28M–
FY2016Dec 31, 2016-$4.20M–
FY2015Dec 31, 2015-$1.70M–
FY2014Dec 31, 2014-$2.04M–
FY2013Dec 31, 2013-$2.52M-9142.8%
FY2012Dec 31, 2012$27.89K–
FY2011Dec 31, 2011-$1.45M–
FY2010Dec 31, 2010-$1.20M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$529.41K–
Q1 FY2026Mar 31, 2026-$157.71K–
Q4 FY2025Dec 31, 2025-$4.21M–
Q3 FY2025Sep 30, 2025-$892.19K–
Q2 FY2025Jun 30, 2025-$1.08M–
Q1 FY2025Mar 31, 2025-$640.64K–
Q4 FY2024Dec 31, 2024-$1.27M–
Q3 FY2024Sep 30, 2024-$580.41K–
Q2 FY2024Jun 30, 2024-$1.65M–
Q1 FY2024Mar 31, 2024-$508.93K–
Q4 FY2023Dec 31, 2023-$2.72M–
Q3 FY2023Sep 30, 2023-$1.97M–
Q2 FY2023Jun 30, 2023-$2.38M–
Q1 FY2023Mar 31, 2023-$1.76M–
Q4 FY2022Dec 31, 2022-$5.00M–
Q3 FY2022Sep 30, 2022-$2.36M–
Q2 FY2022Jun 30, 2022-$1.57M–
Q1 FY2022Mar 31, 2022-$999.53K–
Q4 FY2021Dec 31, 2021-$2.00M–
Q3 FY2021Sep 30, 2021-$993.98K–
Q2 FY2021Jun 30, 2021-$1.11M–
Q1 FY2021Mar 31, 2021-$836.05K–
Q4 FY2020Dec 31, 2020-$1.42M–
Q3 FY2020Sep 30, 2020-$1.09M–
Q2 FY2020Jun 30, 2020-$200.90K–
Q1 FY2020Mar 31, 2020-$2.05M-2928980.0%
Q4 FY2019Dec 31, 2019-$395.81K-107.2%
Q3 FY2019Sep 30, 2019-$558.43K–
Q2 FY2019Jun 30, 2019-$114.81K–
Q1 FY2019Mar 31, 2019$70–
Q4 FY2018Dec 31, 2018$5.49M+1053.2%
Q3 FY2018Sep 30, 2018-$1.64M–
Q2 FY2018Jun 30, 2018-$1.66M–
Q1 FY2018Mar 31, 2018-$2.19M–
Q4 FY2017Dec 31, 2017$475.96K–
Q3 FY2017Sep 30, 2017-$1.61M–
Q2 FY2017Jun 30, 2017-$1.79M–
Q1 FY2017Mar 31, 2017-$1.36M–
Q4 FY2016Dec 31, 2016-$517.80K–
Q3 FY2016Sep 30, 2016-$1.19M–

More Bio Key International figures

See a number that looks wrong?